Prof Mohamed Labib Salem, MSc, PhD - Faculty of Science, Tanta University - Prof. of Immunology and Director, Grants, Innovation & Technology Transfer Center

Prof Mohamed Labib Salem

MSc, PhD

Faculty of Science, Tanta University

Prof. of Immunology and Director, Grants, Innovation & Technology Transfer Center

Tanta, Gharbia | Egypt

Main Specialties: Biotechnology

Additional Specialties: Basic and transnational Immunology

ORCID logohttps://orcid.org/0000-0003-0840-5291


Top Author

Prof Mohamed Labib Salem, MSc, PhD - Faculty of Science, Tanta University - Prof. of Immunology and Director, Grants, Innovation & Technology Transfer Center

Prof Mohamed Labib Salem

MSc, PhD

Introduction

Mohamed L. Salem (PhD, 1995) is the Professor of Immunology at Tanta University, Egypt and was Visiting Professor at Hollings Cancer Center and Department of Microbiology and Immunology, Medical University of South Carolina, USA. Dr. Salem is the Founder and Director of Center of Excellence in Cancer Research, Tanta University, Egypt and Founder and Chairman of Egyptian Association for Cancer Research. He is among the founding members of the Middle Eastern Association for Cancer Research, Canada. Dr Salem is also the Director of Delta Development Research Center which is a regional branch of Academy of Scientific Research and Technology (ASRT), Egypt; Director of the Grant, Innovation & Technology Transfer Center. Dr. Salem obtained his PhD in 1995 through a channel system between Tanta University, Egypt and Kyushu University, Japan. From 1997 -2001, he was a Postdoctoral Fellow at Kyushu University, Japan and from 2002-2010 as an Assistant Professor at Medical University of South Carolina, USA. Dr. Salem is member of several national committees including National Committee for Professorship Promotion, National Committee for the Biological Sciences, National Committee for Scientific Research Strategies, National Committee for Basic Sciences Sector at the Supreme Council of the Egyptian Universities, and National Committee of the Special Basic Science Sector at the Academy of Scientific Research and Technology, Egypt. Dr Salem won the State Incentive Award in 2004 in Biology, the State Excellence Award in 2010 in Basic Sciences from the Academy of Scientific Research and Technology, Egypt, and Tanta University Esteemed Award, Tanta University, Egypt in 2015. His h-index is 26 and published about 115 articles in peer-reviewed journals and attended more than 100 national and international workshops and conferences in Immunology. He supervised more than 55 Master and PhD students. He is a member of several editorial boards of peer-reviewed journals as well as ad hoc reviewer for more than 80 journals. He has been invited to give scientific talks in Egypt, UAE, Jordan, Saudi Arabia, USA, China and Canada. Dr Salem’s research focuses on understanding the cellular and molecular mechanisms underlying how cancer and virus escape from host immunity, in particular the rules of the immunosuppressive cells including lymphoid and myeloid lineages as well as developing effective anticancer immunotherapy strategies. His research projects have been funded by National Institute of Health, USA, Science and Technology Development Fund (STDF), Egypt, USA National Academy of Sciences, Tanta University, Egypt, private foundation and industry.

Primary Affiliation: Faculty of Science, Tanta University - Tanta, Gharbia , Egypt

Specialties:

Additional Specialties:

Research Interests:


View Prof Mohamed Labib Salem’s Resume / CV

Education

Dec 2006
Tanta University
Professorship
Immunology
Feb 2002
Mecical University of South Carolina, USA
Assistant Professor
Cancer Immunology
May 2001
Mecical University of South Carolina, USA
PostDoctoral Fellowship
Cancer Immunology
Feb 2001
Tanta University
Assiatant Professorship
Immunology
Oct 1997
Kyushu University, Japan
PostDoctoral Fellowship
Cancer Immunology
Dec 1995
Tanta University
PhD
ImmunoEndocrinology
Oct 1992
Kyushu University, Japan
Doctoral fellowship
Immunology
Sep 1989
Tanta University
MSc
Comparative Vertebrate Anatomy
May 1984
Tanta University
BSc
Zoology

Experience

Jul 2015
Tanta University Estimated Award
Awardee
Awardd by Tanta University, Egypt
Jun 2010
State Excellence Award in Basic Science
Awardee
Awarded by Academy of Scientific Research and Technology, Egypt
Jul 2004
State Incentive Award in Basic Science
Awardee
Awarded by Academy of Scientific Research and Technology, Egypt

Publications

95Publications

301Reads

946Profile Views

584PubMed Central Citations

Comparative expression of caspases and annexin V in benign and malignant ovarian tumors.

J Cancer Res Ther 2018 Jul-Sep;14(5):1042-1048

Department of Biology, Jazan University, Jizan, KSA.

View Article

Download full-text PDF

Source
http://www.cancerjournal.net/text.asp?2018/14/5/1042/187282
Publisher Site
http://dx.doi.org/10.4103/0973-1482.187282DOI Listing
October 2018
13 Reads

Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia.

J Dermatolog Treat 2018 Aug 6;29(5):431-440. Epub 2018 Mar 6.

g Department of Zoology, Immunology and Biotechnology Unit, Faculty of Science , Center of Excellence in Cancer Research, Tanta University , Tanta , Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2016.1227419DOI Listing
August 2018
34 Reads
2 Citations
1.764 Impact Factor

Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.

Immunopharmacol Immunotoxicol 2018 Apr 1;40(2):158-167. Epub 2018 Feb 1.

a Center of Excellence in Cancer Research (CECR), Tanta University , Tanta , Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08923973.2018.1424897DOI Listing
April 2018
21 Reads
1.110 Impact Factor

High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients.

Immunol Invest 2018 Feb 28;47(2):169-180. Epub 2017 Nov 28.

a Faculty of Medicine, Department of Tropical Medicine , Tanta University , Tanta , Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08820139.2017.1407787DOI Listing
February 2018
18 Reads
1.903 Impact Factor

IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.

Immunopharmacol Immunotoxicol 2017 Aug 4;39(4):188-198. Epub 2017 May 4.

f City of Scientific Research and Technological Applications , Pharmaceutical and Fermentation Industries Development Center , New Burg El Arab , Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08923973.2017.1320670DOI Listing
August 2017
62 Reads
1.110 Impact Factor

Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8 T-cell response.

J Immunotoxicol 2016 11 15;13(6):784-792. Epub 2016 Jul 15.

f Surgery Department and Hollings Cancer Center , Medical University of South Carolina , Charleston , SC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1547691X.2016.1194917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669798PMC
November 2016
28 Reads
1.910 Impact Factor

Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide.

Cell Immunol 2012 Mar-Apr;276(1-2):67-74. Epub 2012 Apr 11.

Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2012.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787597PMC
October 2012
24 Reads
4 Citations
1.924 Impact Factor

Correlation of viral load with bone marrow and hematological changes in pale patients with chronic hepatitis C virus.

Arch Virol 2012 Aug 9;157(8):1579-86. Epub 2012 May 9.

Department of Tropical Medicine and Infectious Diseases, Tanta University, Tanta, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00705-012-1321-zDOI Listing
August 2012
15 Reads
1 Citation
2.282 Impact Factor

Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

J Am Coll Surg 2012 Apr 22;214(4):700-7; discussion 707-8. Epub 2012 Feb 22.

Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2011.12.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429131PMC
April 2012
12 Reads
14 Citations
5.122 Impact Factor

Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.

Immunol Lett 2011 Jun 23;137(1-2):9-14. Epub 2011 Feb 23.

Immunology and Biotechnology Unit, Department of Zoology, Tanta University, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2011.02.019DOI Listing
June 2011
6 Reads
7 Citations
2.512 Impact Factor

Using poly-N-acetyl glucosamine gel matrix to deliver IL-12 with anti-schistosomasis vaccination.

J Infect Dev Ctries 2010 Jun 3;4(5):318-28. Epub 2010 Jun 3.

Medical University of South Carolina, Charleston, SC, USA.

View Article

Download full-text PDF

Source
June 2010
7 Reads
2 Citations
1.270 Impact Factor

Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Cancer Immunol Immunother 2010 Mar 18;59(3):341-53. Epub 2009 Nov 18.

Surgery Department, Medical University of South Carolina, Charleston, 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0792-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070377PMC
March 2010
8 Reads
8 Citations
3.941 Impact Factor

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Cancer Immunol Immunother 2009 Jan 30;58(1):49-59. Epub 2008 Apr 30.

Department of Surgery, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0523-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401888PMC
January 2009
7 Reads
354 Citations
3.941 Impact Factor

Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity.

J Interferon Cytokine Res 2006 Sep;26(9):593-608

Department of Surgery, Section of Surgical Oncology, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jir.2006.26.593DOI Listing
September 2006
11 Reads
17 Citations
2.000 Impact Factor

Immunomodulatory and therapeutic properties of the Nigella sativa L. seed.

Int Immunopharmacol 2005 Dec 1;5(13-14):1749-70. Epub 2005 Jul 1.

Department of Surgery, Section of Surgical Oncology, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2005.06.008DOI Listing
December 2005
10 Reads
97 Citations
2.472 Impact Factor

Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production.

Curr Drug Targets Inflamm Allergy 2004 Mar;3(1):97-104

Section of Surgical Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
March 2004
10 Reads
45 Citations

A role for the peripheral blood fibrocyte in leishmaniasis?

Trends Parasitol 2004 Jan;20(1):12

View Article

Download full-text PDF

Source
January 2004
8 Reads
1 Citation
6.204 Impact Factor

Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.

J Immunol 2002 Nov;169(9):4928-35

Department of Surgery, Section of Surgical Oncology, Medical University of South Carolina, Charleston 29425, USA.

View Article

Download full-text PDF

Source
November 2002
7 Reads
32 Citations
4.922 Impact Factor

Top co-authors

David J Cole
David J Cole

Medical University of South Carolina

6
Mark P Rubinstein
Mark P Rubinstein

Medical University of South Carolina

3
William E Gillanders
William E Gillanders

Washington University School of Medicine

2
Marina Demcheva
Marina Demcheva

Marine Polymer Technologies

2
Mohamed Nassef
Mohamed Nassef

Laboratory of Marine Environmental Science

2
Christophe L Nguyen
Christophe L Nguyen

Medical University of South Carolina

1
Richard Bucala
Richard Bucala

Yale University School of Medicine

1